Yongsheng Wang

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · The Lancet Respiratory Medicine · 2020 · 505 citations

Medicine, Oncology, Pharmacology +13

Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer

Yang Shu, Weihan Zhang, Qianqian Hou et al. · Nature Communications · 2018 · 143 citations · Full text

Medicine, Genetics, Oncology +17

Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians

Yongsheng Wang, Gerald Schmid‐Bindert, Caicun Zhou · Therapeutic Advances in Medical Oncology · 2011 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

Wenhao Guo, Yu Zhang, Ting Chen et al. · Journal of Cancer Research and Clinical Oncology · 2010 · 97 citations · Full text

Medicine, Molecular Biology, Oncology +9

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial

Mengzhao Wang, Yun Fan, Meili Sun et al. · The Lancet Respiratory Medicine · 2023 · 66 citations

Medicine, Oncology, Pharmacology +12